Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Look up keyword
Like this
0 of .
Results for:
No results containing your search query
P. 1
High-Dose Vitamin d3 Supplementation in a Cohort of Breastfeeding Mothers and Their Infants (a 6 Month Followup Pilot Study)

High-Dose Vitamin d3 Supplementation in a Cohort of Breastfeeding Mothers and Their Infants (a 6 Month Followup Pilot Study)

Ratings: (0)|Views: 11|Likes:
Published by jamie_clark_2
Medical vaccinationcancerclassifiedsgovernment documents
Medical vaccinationcancerclassifiedsgovernment documents

More info:

Published by: jamie_clark_2 on Oct 13, 2012
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as ODT, PDF, TXT or read online from Scribd
See more
See less





Breastfeed Med.2006 Summer;1(2):59-70.
High-dose vitamin D3 supplementation in acohort of breastfeeding mothers and theirinfants: a 6-month follow-up pilot study.
Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina 29425,USA. wagnercl@musc.edu <wagnercl@musc.edu>
To examine the effect of high-dose maternal vitamin D(3) (vitD) supplementation on the nutritionalvitD status of breastfeeding (BF) women and their infants compared with maternal and infant controlsreceiving 400 and 300 IU vitD/day, respectively.
Fully lactating women (n = 19) were enrolled at 1-month postpartum into a randomized- control pilottrial. Each mother received one of two treatments for a 6-month study period: 0 or 6000 IU vitD(3) plus a prenatal vitamin containing 400 IU vitD(3). The infants of mothers assigned to the controlgroup received 300 IU vitD(3)/day; those infants of mothers in the high-dose group received 0 IU(placebo). Maternal serum and milk vitD and 25(OH)D were measured at baseline then monthly;infant serum vitD and 25(OH)D were measured at baseline, and months 4 and 7. Urinarycalcium/creatinine ratios were measured monthly in both mothers and infants. Dietary and BF historyand outdoor activity questionnaires were completed at each visit. Changes in skin pigmentation weremeasured by spectrophotometry. Data were analyzed using chi-square, t-test, and analysis of variance(ANOVA) on an intent-to-treat basis.
High-dose (6400 IU/day) vitD(3) safely and significantly increased maternal circulating 25(OH)D andvitD from baseline compared to controls (p < 0.0028 and 0.0043, respectively). Mean milk antirachitic activity of mothers receiving 400 IU vitD/day decreased to a nadir of 45.6 at visit four andvaried little during the study period (45.6-78.6 IU/L), whereas the mean activity in the 6400 IU/daygroup increased from 82 to 873 IU/L (p < 0.0003). There were no differences in circulating 25(OH)Dlevels of infants supplemented with oral vitD versus infants whose only source of vitD was breastmilk.
With limited sun exposure, an intake of 400 IU/day vitamin D(3) did not sustain circulating maternal25(OH)D levels, and thus, supplied only extremely limited amounts of vitamin D to the nursing infantvia breast milk. Infant levels achieved exclusively through maternal supplementation were equivalentto levels in infants who received oral vitamin D supplementation. Thus, a maternal intake of 6400

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->